Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

On March 5, 2025, the U.S. District Court for the Northern District of Texas denied the Outsourcing Facilities Association’s motion for a ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Spinal cord injury (SCI) resulting in severe paralysis is known to deteriorate the quality of life of humans. However, the ...

These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...

Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...

The end of compounded versions of weight-loss drugs is near, leaving patients scrambling for alternatives. Some “copycat” ...

Illegal networks are flooding the market with counterfeit weight loss drugs, posing a serious threat to public health. The ...